CDIO
Price
$4.60
Change
+$0.14 (+3.14%)
Updated
Jul 16 closing price
Capitalization
8M
RCUS
Price
$9.26
Change
+$0.23 (+2.55%)
Updated
Jul 16 closing price
Capitalization
980.5M
14 days until earnings call
Interact to see
Advertisement

CDIO vs RCUS

Header iconCDIO vs RCUS Comparison
Open Charts CDIO vs RCUSBanner chart's image
Cardio Diagnostics Holdings
Price$4.60
Change+$0.14 (+3.14%)
Volume$19.94K
Capitalization8M
Arcus Biosciences
Price$9.26
Change+$0.23 (+2.55%)
Volume$494.37K
Capitalization980.5M
CDIO vs RCUS Comparison Chart in %
Loading...
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDIO vs. RCUS commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIO is a Buy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (CDIO: $4.60 vs. RCUS: $9.26)
Brand notoriety: CDIO and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDIO: 28% vs. RCUS: 45%
Market capitalization -- CDIO: $8M vs. RCUS: $980.5M
CDIO [@Biotechnology] is valued at $8M. RCUS’s [@Biotechnology] market capitalization is $980.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileCDIO’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • CDIO’s FA Score: 0 green, 5 red.
According to our system of comparison, both RCUS and CDIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDIO’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • CDIO’s TA Score: 3 bullish, 4 bearish.
  • RCUS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than CDIO.

Price Growth

CDIO (@Biotechnology) experienced а +18.19% price change this week, while RCUS (@Biotechnology) price change was -0.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

Reported Earning Dates

CDIO is expected to report earnings on May 15, 2025.

RCUS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($980M) has a higher market cap than CDIO($8M). RCUS YTD gains are higher at: -37.811 vs. CDIO (-83.279). CDIO has higher annual earnings (EBITDA): -5.46M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. CDIO (9.69M). CDIO has less debt than RCUS: CDIO (605K) vs RCUS (60M). RCUS has higher revenues than CDIO: RCUS (141M) vs CDIO (19.9K).
CDIORCUSCDIO / RCUS
Capitalization8M980M1%
EBITDA-5.46M-377M1%
Gain YTD-83.279-37.811220%
P/E RatioN/AN/A-
Revenue19.9K141M0%
Total Cash9.69M997M1%
Total Debt605K60M1%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDIORCUS
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMEA1.910.13
+7.30%
Biomea Fusion
CLCO6.730.07
+1.05%
Cool Company Ltd
INSW38.370.08
+0.21%
International Seaways
SCKT1.21-0.02
-2.02%
Socket Mobile
CF92.60-3.30
-3.44%
CF Industries Holding

CDIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with KRRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
+3.18%
KRRO - CDIO
35%
Loosely correlated
+3.95%
TARA - CDIO
31%
Poorly correlated
+3.28%
VOR - CDIO
29%
Poorly correlated
-5.57%
ABSI - CDIO
28%
Poorly correlated
+6.61%
RCUS - CDIO
26%
Poorly correlated
+2.55%
More

RCUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+2.55%
XNCR - RCUS
51%
Loosely correlated
+4.62%
IDYA - RCUS
49%
Loosely correlated
+3.36%
TRDA - RCUS
48%
Loosely correlated
+0.16%
ACLX - RCUS
48%
Loosely correlated
+3.74%
OCUL - RCUS
47%
Loosely correlated
+1.44%
More